---

title: Streptococcal Pharyngitis
authors:
    - Michelle Lin, MD
created: 2010/07/30
updates:
categories:
    - ENT
    - Infectious Disease
    - EBM
---

# Streptococcal Pharyngitis

- **Most cases of pharyngitis:** Viral
- **Most cases of bacterial pharyngitis:** Group A beta-hemolytic streptococcus
- **Incidence:** 15-30% (children) and 5-20% (adults) 
- **Peak season:**  late winter/ early spring
- **Transmission:** respiratory secretions
- **Incubation period:**  24-72 hours
- Antibiotics shorten symptoms by 16 hours

## Modified Centor Scoring

| **Criteria **                     | **Points** |
| --------------------------------- | :--------: |
| Absence of cough                  |      1     |
| Swollen and tender cervical nodes |      1     |
| Temp >100.4F (38C)                |      1     |
| Tonsillar exudates or swelling    |      1     |
| Patient age:                      |            |
| • 3-14 yr                         |      1     |
| • 15-44 yr                        |      0     |
| • ≥ 45 yr                         |     -1     |

| **Score** | **Incidence of GABHS** | **Plan**                        |
| :-------: | :--------------------: | ------------------------------- |
|     ≤0    |         1-2.5%         | No testing, no antibiotics      |
|     1     |          5-10%         | No testing, no antibiotics      |
|     2     |         11-17%         | Do rapid antigen test           |
|     3     |         28-35%         | Do rapid antigen test           |
|     ≥4    |         51-53%         | No testing, empiric antibiotics |

## National Organization Guidelines

### How to screen for strep pharyngitis

| **Group**        | **Recommendations**                                                                       |
| ---------------- | ----------------------------------------------------------------------------------------- |
| **ACP/CDC/AAFP** | Use Centor criteria to decide testing and antibiotics                                     |
| **AAP**          | Use clinical & epidemiological findings to assess risk for GABHS (includes Centor scores) |
| **IDSA**         | Use clinical & epidemiological findings to assess risk for GABHS (includes Centor scores) |

### Diagnostic Test

| **Group**        | **Recommendations**                                           |
| ---------------- | ------------------------------------------------------------- |
| **ACP/CDC/AAFP** | Rapid antigen test only for Centor scores of 2 or 3 only      |
| **AAP**          | Rapid antigen test or throat culture for ALL patients at risk |
| **IDSA**         | Rapid antigen test or throat culture for ALL patients at risk |

### Backup culture needed if rapid Ag test is negative?

| **Group**        | **Recommendations**          |
| ---------------- | ---------------------------- |
| **ACP/CDC/AAFP** | Adults: No; Pediatrics: Yes  |
| **AAP**          | Adults: N/A; Pediatrics: Yes |
| **IDSA**         | Adults: No; Pediatrics: Yes  |

### Who gets antibiotics?

| **Group**        | **Recommendations**                                                                   |
| ---------------- | ------------------------------------------------------------------------------------- |
| **ACP/CDC/AAFP** | Empiric abx for Centor score of ≥ 4, or those with positive rapid antigen test result |
| **AAP**          | Positive rapid antigen test or throat culture                                         |
| **IDSA**         | Positive rapid antigen test or throat culture                                         |

### Which antibiotic?

| **Group**        | **Recommendations**                                                                                                                              |
| ---------------- | ------------------------------------------------------------------------------------------------------------------------------------------------ |
| **ACP/CDC/AAFP** | Oral <span class="drug">penicillin</span> V, IM <span class="drug">penicillin</span> G benzathine, or oral <span class="drug">amoxacillin</span> |
| **AAP**          | Oral <span class="drug">penicillin</span> V, IM <span class="drug">penicillin</span> G benzathine, or oral <span class="drug">amoxacillin</span> |
| **IDSA**         | Oral <span class="drug">penicillin</span> V, IM <span class="drug">penicillin</span> G benzathine, or oral <span class="drug">amoxacillin</span> |

### Which antibiotic for PCN allergy?

| **Group**        | **Recommendations**                                                     |
| ---------------- | ----------------------------------------------------------------------- |
| **ACP/CDC/AAFP** | Oral <span class="drug">erythromycin</span>, or first-gen cephalosporin |
| **AAP**          | Oral <span class="drug">erythromycin</span>, or first-gen cephalosporin |
| **IDSA**         | Oral <span class="drug">erythromycin</span>, or first-gen cephalosporin |

- ACP = American College of Physicians
- CDC = Center for Disease Control
- AAFP = American Academy of Family Physicians
- AAP = American Academy of Pediatrics
- IDSA = Infectious Disease Society of America 

## References

- [Choby BA.Diagnosis and treatment of streptococcal pharyngitis.Am Fam Physician. 2009 Mar 1;79(5):383-90.](http://www.ncbi.nlm.nih.gov/pubmed/?term=19275067)
